The U.S. Head of Advanced Bioconjugation Technologies will contribute to the overall R&D strategy by offering Bioconjugation R&D strategic input / roadmap across the ADS platform to generate industry leading/ differentiated offering and outstanding levels of performance in our development and manufacturing operations at Lonza.
Requirements
- Solid experience delivering strong value (new offerings, acceleration, etc) through the development and deployment of innovative bioconjugation technologies in a pharmaceutical /CDMO environment.
- Proven track record /scientific expertise in the development and deployment of complex bioconjugation technologies (linker/payload, process technologies, automation, modeling approaches,etc)
- Proven track record /scientific expertise in the development and tech transfer of various powerful bioconjugation technologies (e.g. drug linkers, process technologies such as TFF, protein chromatography, automation, modeling approaches, etc)
- Established a collaboration network and external recognition as an SME in the field
- Ability to operate at multiple levels from strategic planning to site operational deployment in line with broader R&D and platform objectives
- Confidently prepares high-quality technical analyses and reports for internal or external use
Responsibilities
- Act as R&D lead for bioconjugation process technologies across the ADS organization (R&D, MSAT, Development Services, etc) and partner with relevant leads across Lonza.
- Effectively manage resources and projects in line with prioritized platform needs.
- Collaborate with all relevant R&D teams (Portfolio management, chemical technologies, drug delivery, Analytical, data science and modeling), functions (operations, quality, etc) and relevant operational teams across sites e.g. development services, MSAT, manufacturing for bioconjugation, microbial, mammalian and drug product
- Identify and complete end to end process optimization opportunities within the innovation portfolio in a collaborative fashion.
- Ensure effective deployment of new tools and capabilities in operations, services, commercial development, etc to deliver value to the business
- Accelerate the adoption of high throughput automation and analytics and modeling technologies (inc AI, etc) for bioconjugation including through partnerships / external collaborations.
Other
- Ph.D. in Science, an equivalent professional qualification, or occupational experience in Chemistry, Biology, Biochemical engineering, Biochemistry or equivalent
- A minimum of 5-10+ years of experience in the Pharma CDMO business, with a proven relevant experience in bioconjugation in a pharmaceutical /CDMO setting
- Ability to travel domestically and internationally.
- Self-initiating / self-directed
- Strong communication skills and the capacity to translate technical information into business insights for decision-making process.
